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The effects of epinephrine and vasopressin o  the phosphorylation state of glycogen synthase were studied 
using rat hepatocytes incubated with 32P After the incubation with hormones, “P-labeled glycogen .
synthase was isolated using antibodies against rat liver enzyme. The immunoprecipitate showed a single 
radioactive band @&,88 kDa) when subjected to SDS-gel electrophoresis. Both epinephrine and 
vasopressin inactivated the enzyme and increased the 32P content of glycogen synthase. Cleavage of the 
immunoprecipitate with CNBr yielded two major 32P-labeled fragments of Map,, - 27 and 12 kDa. Both 
hormones increased the 32P content of both fragments. These results prove that epinephrine and 
vasopressin increase the phosphate content of the enzyme promoting its phosphorylation at multiple sites. 
Glycogen synthase Hepatocyte Phosphorylution CNBr peptide 
Epinephrine Vasopressin Hormonal effect 
1. INTRODUCTION 
Glycogen synthase is regulated through 
mechanisms of phosphorylation and dephosphor- 
ylation. In vitro glycogen synthase can be phos- 
phoryiated by different protein kinases at multiple 
sites. Phosphorylation causes the inactivation of 
the enzyme since it produces a change in the kinetic 
properties of glycogen synthase [ 1,2]. 
In vivo several hormones promote the inactiva- 
tion of the enzyme. It is very important to establish 
the relationship between hormonal action and the 
phosphorylation state of the enzyme. Two dif- 
ferent procedures have been used to approach this 
problem. The first is that followed in [3]. These 
authors purified glycogen synthase from rabbit 
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skeletal muscle after injection of hormones to the 
animals and then they established a relationship 
between hormonal action and the phosphate con- 
tent in different regions of the enzyme. In the se- 
cond approach, tissues are incubated or perfused 
with [32P]phosphate and the ‘*P incorporated to 
glycogen synthase fragments after hormonal treat- 
ment is measured. The 32P approach has been used 
in the study of the in vivo phosphorylation of 
glycogen synthase in rat heart [4,5] and in rat 
diaphragms [6]. 
However, no data were avaiIable for the liver en- 
zyme. So far no direct evidence that the inactiva- 
tion of the liver enzyme by glycogenolytic hor- 
mones is a consequence of the introduction of 
phosphates in glycogen synthase had been 
obtained. 
This study was undertaken to establish a rela- 
tionship between hormonal control of gycogen 
synthase activity and the phosphorylation state of 
the enzyme in rat hepatocytes. We prove that both 
epinephrine and vasopressin increase the 32P con- 
tent in two fragments of the enzyme indicating that 
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the effect of these hormones is exerted through 
multisite phosphorylation of glycogen synthase. 
2. MATERIALS AND METHODS 
2.1. Preparation of hepatocyte supernatants 
Suspensions of isolated parenchymal iver cells 
were prepared from 24 h starved male Wistar rats 
(1 SO-220 g) as in [?I. Cells were finally resuspend- 
ed in low phosphate (0.1 mM) Krebs bicarbonate 
buffer (pH7.4), pre-gassed with 02(CO2 (19:l). 
Aliquots (5 ml, 3 x lo6 cells/ml) were poured into 
stoppered vials, pre-incubated with 32Pi (0.1-0.2 
mCi/ml) for 60 min and then stimulated with 
either epinephrine or vasopressin. At the end of the 
hormonal incubations the content of each vial was 
centrifuged (3000 x g, 20s) and the cell pellet im- 
mediately homogenized with 400~1 ice-cold 
medium containing 10 mM Tris (pH 7.0), 150mM 
KF, 15 mM EDTA, 600 mM sucrose, 1 mM PMSF, 
1 mM benz~idine, 50yg/ml leupeptin and 50 mM 
,&mercaptoethanol. The presence of the proteinase 
inhibitors and a high concentration of sucrose was 
fundamental for avoiding proteolytic cleavage of 
the enzyme during homogenization. 
Cell homogenates were centrifuged at 
10 000 x g for 20min and the obtained super- 
natants further centrifuged at 100000 x g for 
60 min to obtain cytosolic supernatants containing 
32P-labeled glycogen synthase. 
Glycogen synthase and phosphorylase activities 
were measured in supernatants of cells simultan- 
eously subjected to the same procedure but 
without 32P being added to the incubation media. 
2.2. Immunoprecipitation of glycogen synthase 
Antibodies to rat liver glycogen synthase were 
raised in rabbits to which several injections of 
homogeneous rat liver glycogen synthase emulsi- 
fied with Freund’s complete adjuvant were given. 
Six weeks after the first injection the rabbits were 
bled and the antiserum was partially purified by 
precipitation with (NH&S04 (45% saturation). 
Cytosolic supernatants were diluted I :1 with 
10 mM Triss (pH 7.0), 150 mM KF, 15 mM EDTA 
buffer. Then 175~1 of the partially purified an- 
tiserum were added to each aliquot. After 4 h of in- 
cubation at 4°C the mixture was centrifuged at 
12 800 x g for 8 min and the pellets washed 3 times 
with 500~1 of the above-mentioned buffer. In this 
step, maintaining the preparation at low tempera- 
ture was essential in avoiding proteolysis of the 
enzyme. 
2.3. Analytical procedures 
Cyanogen bromide treatment of 32P-labeled 
glycogen synthase immunopellets was carried out 
for 12 h at room temperature as in [S]. 
Samples for SDS-PAGE were lyophilized, 
resuspended in 0.5 ml water and lyophilized again. 
Finally, they were resuspended in 30~1 of sample 
buffer containing 40 mM Tris (pH 6.5), 5% SDS, 
0.6 M &mercaptoethanol, 20% sucrose and 
0.0125% bromophenol blue as a marker. Elec- 
trophoresis was performed as in [9] and the gels 
were submitted to indirect autoradiography at 
- 80°C. Developed films scanned at 546 nm. 
Glycogen synthase activity was measured as in 
[lo] and [ 111 and glycogen phosphorylase as in 
]121. 
[y-32P]ATP specific radioactivity was determin- 
ed essentially as in [ 131. 
3. RESULTS 
3.1. rmmunoprecipifat~on of glycogen synthase 
from hepatocyte xtracts 
32P-labeled glycogen synthase was rapidly 
purified from extracts of hepatocytes that had 
been incubated with 32P by immunoprecipitation. 
The antibodies were effective in removing glycogen 
synthase activity from extracts from control or 
hormone-treated hepatocytes. At the concentra- 
tion of antibodies used, glycogen synthase activity 
was completely removed in control, vasopressin 
and epinephrine extracts (fig. 1). However, the an- 
tibodies did not remove any of the glycogen 
phosphorylase activity present in the extracts. 
3.2. Electrophoretic analysis of 32P-labeled 
giycogen synthase from rat hepatocytes 
32P-labeled glycogen synthase from extracts of 
contro1 and hormone-treated hepatocytes was 
precipitated by the specific antibodies. Samples of 
the immunoprecipitates were resuspended after ex- 
tensive washing and subjected to SDS-electro- 
phoresis. Regardless of the hormone treatment, all 
of the radioactivity was present in a single band 
which had the same mobility as purified rat liver 
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Fig.1. Binding of antibodies to glycogen synthase from 
extracts of control and hormonally-treated hepatocytes. 
Hepatocytes were incubated with saline (o), low5 M 
epinephrine (A) or lo-’ M vasopressin ( n ). Extracts 
were prepared and aliquots were added with increasing 
concentrations of control serum or anti-glycogen syn- 
thase antiserum and incubated at 4°C for 4 h. Then 
samples were centrifuged and gIycogen synthase ac- 
tivities (in the presence of 6.6 mM glucose-6P) were 
measured in the supernatants. The results presented 
represent percentages of glycogen synthase activities 
removed by the antibodies. 
glycogen synthase labeled with 32P by rat incuba- 
tion with [y-32P]ATP and the catalytic subunit of 
the rat liver CAMP-dependent protein kinase. The 
radioactive band showed an A4,,, of 88 kDa. If 
proper care was not taken in the preparation of the 
extracts or in the immunoprecipitation procedure, 
a second 32P-hand with an Mapp of 80 kDa could 
be observed, which corresponded to a proteolytic 
fragment of the main subunit (fig.2). The presence 
of sucrose in the homogenization media and tem- 
perature control were the most important factors 
in this regard. 
3.3. CNBr cleavage of the 3zP-labeled glycogen 
syn thase 
Treatment of the 3zP-immunoprecipitates with 
CNBr resulted in the formation of two 32P- 
fragments, The band of iower mobility (peak II) 
had an Map,, of 27 kDa and the faster moving band 
(peak I) had an Mapp of 12 kDa. These fragments 
corresponded with those obtained after CNBr 
cleavage of the purified rat liver glycogen synthase 
phosphorylated with either the catalytic subunit of 
the CAMP-dependent protein kinase or the casein 
kinase-1 purified from rat liver. 
Fig.2. Electrophoretic analysis of 32P-labeled glycogen 
synthase. Immunoprecipitates of glycogen synthase were 
submitted to electrophoresis in 7% acrylamide gels and 
then autoradiograms were obtained. (A,B) Im- 
munoprecipitates from extracts of 32P-Iabeled 
hepatocytes prepared in presence (A) or absence (B) of 
600 mM sucrose. (C) Immunoprecipitate of purified rat 
liver glycogen synthase phosphorylated in vitro by the 
catalytic subunit of rat liver CAMP-dependent protein 
kinase. Molecular masses of standard proteins are 
shown on the right. 
3.4. 32P-iabeling of the ATP by incubation of 
rat hepatocytes with [3’PJphosphate 
Hepatocytes were incubated with [32P]phos- 
phate for 1 h. The [T-~‘P]ATP specific activity 
reached a plateau after approx. 45 min of incuba- 
tion (not shown) and a specific radioactivity of 
25-30 cpm/pmol was achieved. No change in the 
specific radioactivity of [32P]ATP could be 
detected by subsequent hormonal treatment. 
3.5. Hormonal effects on the glycogen synthase 
activity of rat hepatocytes 
Both vasopressin (10M7 M) and epinephrine 
(10m5 M) caused the inactivation of glycogen syn- 
thase. This effect was magnified when measured 
by the low glucose (i-P/high glucose 4-P activity 
ratio method (table 1). The time of incubation 
with the hormones was fixed at 8 min for 
vasopressin and 5 min for epinephrine, as in 
previous experiments it was observed that effects 
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Table 1 
Effects of epinephrine and vasopressin on glycogen synthase 
Control 
Vasopressin 
Epinephrine 
GS activity ratio 
(0.25 mM G6P/lO 
mM G6P 
44+0.9 
35+ 1.3 
36+ 1.5 
CNBr 32P-fragments 
Peak I Peak II 
100 100 
390*41 296+51 
403 f 29 29Ok 35 
Peak II/Peak I 
2.2kO.3 
1.4kO.l 
1.5kO.2 
Hepatocytes were incubated with or without hormones in duplicate samples with or without 32P 
before extracts were prepared. Glycogen synthase low G6P/high G6P activity ratio was measured 
in extracts of cells not incubated with 32P. In extracts of 32P-labeled cells glycogen synthase was im- 
munoprecipitated, treated with CNBr and subjected to electrophoresis. Autoradiograms of gels 
were scanned and the peaks corresponding to the two CNBr fragments were integrated. Results are 
expressed as  percentage of the values of the peaks from control cells. Results are means +_ SE of 
5 experiments 
of these hormones were maximal at the above in- 
dicated times. Similarly, the concentration used 
corresponded to maximal doses. 
3.6. Hormonal effects on the 32P content of 
both CNBr fragments of glycogen synthase 
32P-labeled glycogen synthase was immunopre- 
cipitated from extracts of control and hormone- 
treated hepatocytes and subjected to SDS-electro- 
phoresis. Autoradiograms were prepared and scan- 
ned as indicated. Incubation of the cell with either 
vasopressin or epinephrine resulted in an increase 
of the peak of 32P-labeled glycogen synthase. In 
order to determine if these hormones preferentially 
affected the phosphorylation of different CNBr 
fragments of the enzyme, autoradiograms from 
gels of samples that had been treated with CNBr 
were scanned. 
Incubation of the hepatocytes with both 
epinephrine or vasopressin resulted in an increase 
in the total amount of the radioactivity present in 
both CNBr fragments (fig.3). Radioactivity in 
peak II was increased about 3 times and that in 
peak I about 4 times. Therefore the ratio of the 
radioactivity associated with peak II to that in 
peak I, which was approx. 2.2: 1 in the control, 
decreased to about 1.4: 1 in hormone-treated 
hepatocytes (table 1). 
4. DISCUSSION 
The results presented prove that rat hepatocyte 
glycogen synthase is phosphorylated in vivo at 
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Fig.3. Electrophoretic analysis of the CNBr fragments 
of 32P-labeled glycogen synthase. Samples of the im- 
munoprecipitates were cleaved with CNBr before being 
subjected to electrophoresis in 15% acrylamide gels. 
Autoradiograms were obtained and then scanned. 
(A,C,D) Immunoprecipitates of 32P-Iabeled glycogen 
synthase obtained from control (A), epinephrine (C) and 
vasopressin (D) treated hepatocytes. (B) The pattern of 
CNBr cleavage products of partially proteolyzed 
glycogen synthase. The dotted lines in (A) correspond to 
CNBr fragments of purified glycogen synthase 
phosphorylated in vitro with the catalytic subunit of 
CAMP-dependent protein ki ase. 
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several sites and that its state of phosphorylation is 
increased by hormones which inactivate the 
enzyme. 
Our experimental approach was to incubate 
hepatocytes with 32P followed by immunoprecipi- 
tation of the enzyme. This approach which has 
been useful in the study of glycogen synthase from 
rat heart [4,5] or rat diaphragm [6] has also been 
very useful for the liver system. In this case we 
have used antibodies raised in goat against he rab- 
bit muscle enzyme. The “P-labeled glycogen syn- 
thase immunoprecipitated from rat hepatocytes 
had an Map,, of 88 kDa. This value was identical to 
that of homogeneous rat liver glycogen synthase 
phosphorylated in vitro by different protein 
kinases. This immunoprecipitation was highly 
specific since the Mapp 88 kDa was the only 
radioactive band obtained and the antibody did 
not eliminate any of the phosphorylase activity 
present in the extracts. However, maximal care 
had to be taken to avoid proteolysis of the enzyme. 
If not, a proteolytic band of Mapp 80 kDa could 
easily appear. 
Treatment of glycogen synthase with CNBr gives 
rise to two “P-labeled fragments. These fragments 
coincide with those obtained by CNBr cleavage of 
the purified rat liver glycogen synthase phosphor- 
ylated in vitro by different protein kinases. 
Therefore in vivo [32P]phosphate is introduced in 
the same regions of the glycogen synthase molecule 
which are also phosphorylated in vitro. It is worth 
noting that the muscle enzyme is also phosphoryl- 
ated in vitro as well as in vivo at two CNBr frag- 
ments. 
An important conclusion of this paper is that 
both vasopressin and epinephrine increase the 
phosphate content in both CNBr fragments and 
although more phosphate was actually introduced 
in the largest fragment (II), on a percentage basis 
the increase in the radioactivity in the smaller 
CNBr fragment was more pronounced. Therefore 
these results suggest multiple phosphorylation of 
liver glycogen synthase after hormonal treatment. 
A similar conclusion was reached regarding muscle 
in [3] and [6]. 
Experiments in progress in our laboratory on the 
site specificity of several rat liver protein kinases 
acting on rat liver glycogen synthase will permit a 
comparison between the sites phosphorylated in 
vivo in response to hormonal treatment and those 
phosphorylated in vitro by the different protein 
kinases. 
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